Delivery Order 75F40118D10020-75F40118F01001
- This is a delivery order awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to develop and enhance the current Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including...
- The Food and Drug Administration issued a delivery order to Acumen LLC (doing business as Medric) on September 30, 2021, under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics parent IDIQ, with a ceiling value of $16.86 million for conduct of surveillance activities supporting safety and effectiveness of biologics for COVID-19 supported activities. Place of performance is Hillsborough, CA. The order is priced on a time-and-materials basis with an ultimate...
- This is a $5,967,111.25 delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to IQVIA Government Solutions Inc., a provider of healthcare data, analytics, and related services to U.S. federal agencies. The contract was awarded under the FDA's BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract is for the development and...
- The U.S. Department of Health and Human Services Food and Drug Administration awarded a $14,609,200.89 delivery order contract to International Business Machines Corporation (IBM) for the "DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGICAL PRODUCTS". This contract is a Time and Materials type under the BEST Initiative - New and Innovative Methods for Automated Reporting master IDIQ. The contract does not have a set-aside designation. IBM, as...
- The Food and Drug Administration issued a delivery order to Iqvia Government Solutions Inc. on September 29, 2025, with a ceiling value of $4,979,537.23 under the CBER BEST Initiative 3 – Data Sources for Surveillance of Biologics indefinite delivery contract for health care data sources supporting biologics surveillance. The CBER BEST Initiative 3 is a multiple-award IDC focused on effectiveness and safety surveillance data for biologics. Place of performance is Falls Church, VA. The order is...
- The Food and Drug Administration awarded a definitive contract to Acumen LLC for the BEST (Biologics Effectiveness and Safety) Initiative Coordinating Center on September 26, 2025, with a ceiling value of $6.26 million and ultimate completion date of September 29, 2026. The contract is priced on a time-and-materials basis with no set-aside. Place of performance is Hillsborough, CA. The originating solicitation supports post-market surveillance coordination for the FDA's biologic product...
- The Food and Drug Administration issued a delivery order to Iqvia Government Solutions Inc. on September 27, 2024, with a ceiling value of $6,154,872.75 under the CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics, a multiple-award IDC for the Biologics Effectiveness and Safety (BEST) Initiative supporting post-market drug safety surveillance and regulatory decision-making through comprehensive healthcare data access. Place of performance is Falls Church, VA. The order is priced...
- This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) for the development of new and innovative methods for automated reporting for biological products regulated by the FDA's Center for Biologics Evaluation and Research (CBER). The contract has a potential value of $6,999,176.74 and is on a time and materials pricing basis. It was awarded under the BEST Initiative master...
- The Department of Health and Human Services Food and Drug Administration awarded a $5,273,171.50 delivery order contract to Iqvia Government Solutions Inc. to conduct surveillance activities for the safety and effectiveness of biologics. This contract is part of the BEST Initiative, a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle for data tools and infrastructure to support surveillance of biologics. Iqvia Government Solutions is a for-profit organization that has...
- This is a $10,685,766.00 cost-plus-fixed-fee delivery order contract awarded by the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The contract is for the Biologic Effectiveness and Safety (BEST) Innovative Methods (IM) Program, which involves providing comprehensive scientific, technical, and acquisition support services to the...
- 75F40118D10020Indefinite Delivery Contract
- 75F40118D10020-75F40118F01001Delivery Order
This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric, to develop and enhance the FDA's Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including vaccines, blood and blood products, tissues, and advanced therapies. The contract has a potential value of $2,888,103.47 and is a Delivery Order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics, an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract is not set aside for any socioeconomic category.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Biologics Effectiveness and Safety (BEST) Initiative: Data, Tools and Infrastructure for Surveillance of Biologics | FDA-18-223-SOL-1196209 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 5/25/18, 3:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 6/5/19 | |
| P00001 | Other Administrative Action | $0 | 11/16/18 | |
| Not listed | Not listed | $2.9m | 9/21/18 |